Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmagreen Biotech Inc PHBI

Healthcare
Pharmagreen Biotech, Inc. is a Canada-based company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a... see more

Recent & Breaking News (OTCPK:PHBI)

Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project

GlobeNewswire October 10, 2024

Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress

GlobeNewswire September 19, 2024

PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations

Accesswire January 24, 2024

PHBI - Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation

GlobeNewswire September 5, 2023

PHBI Pharmgreen Launches Online Sales for Its MaxGenomic(TM) Supplement Product

GlobeNewswire February 8, 2023

Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador

GlobeNewswire November 29, 2022

PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development

GlobeNewswire September 22, 2022

PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch

GlobeNewswire September 8, 2022

PHBI - Pharmagreen Provides Updates On Its Business Developments Beyond Just Cannabis

GlobeNewswire July 12, 2022

PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC

GlobeNewswire May 24, 2022

PHBI - Pharmagreen Biotech Provides Updates on Its Ongoing Business Developments

GlobeNewswire March 24, 2022

PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC.

GlobeNewswire January 20, 2022

PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC

Newsfile January 20, 2022

PHBI - Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company

GlobeNewswire January 6, 2022

PHBI Pharmagreen Announces Affirmed MOU to Acquire Licensed California Cannabis Company

GlobeNewswire January 6, 2022

Pharmagreen Biotech Announces Up-Listing to OTCQB Venture Market

Newsfile December 21, 2021

PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market

GlobeNewswire December 21, 2021

PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market

GlobeNewswire December 20, 2021

PHBI - Pharmagreen Previews Imminent Next Strategic Steps Advancing Its Proprietary Cannabis Tissue Culture Technology Into Recurring Revenue Generation

GlobeNewswire December 16, 2021

PHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard

PR Newswire December 9, 2021